LCID
Lucid Group, Inc.
LCID offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
PII
Polaris Inc.
PII has a slight edge over LCID overall, supported by lower modeled downside.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
PII Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Weak |
PII's revenue is currently healthy, but its profitability, cash flow and balance sheet are under pressure.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
PII PE Valuation
PII has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
PII Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for PII, with profitability improving. However, they disagree widely on these estimates.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID has the edge over PII on earnings, with more consistent year-over-year improvement.
PII Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.84 | — |
| Q3 2026 | -$3.69 | -$1.03 |
| Q2 2026 | -$4.63 | -$2.74 |
| Q1 2026 | -$7.84 | -1204% |
| Q4 2025 | -$8.18 | -519% |
| Q3 2025 | -$2.66 | -174% |
| Q2 2025 | -$1.89 | -133% |
| Q1 2025 | $0.71 | -90% |
| Q4 2024 | $1.95 | -78% |
PII lost $3.69 per share over the past year, a bigger loss than the year before.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over PII on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
PII Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2B | +11% |
| Q2 2026 | $2B | +9.2% |
| Q1 2026 | $1.7B | +8% |
| Q4 2025 | $1.9B | +9.5% |
| Q3 2025 | $1.8B | +6.9% |
| Q2 2025 | $1.9B | -5.5% |
| Q1 2025 | $1.5B | -12% |
| Q4 2024 | $1.8B | -23% |
PII's revenue is recovering but still below its 2022 peak: $2B last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.6% | +2.5 points |
| Q2 2026 | 7.4% | +8.1 points |
| Q1 2026 | -2.4% | 0 points |
| Q4 2025 | -17% | -20 points |
| Q3 2025 | 1.1% | -2.7 points |
| Q2 2025 | -0.7% | -6.8 points |
| Q1 2025 | -2.4% | -4.6 points |
| Q4 2024 | 3.8% | -2.5 points |
PII has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
PII Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $315.3M | +170% |
| Q2 2026 | $186.1M | -33% |
| Q1 2026 | -$349.9M | -835% |
| Q4 2025 | $114M | -17% |
| Q3 2025 | $116.7M | +$149.1M |
| Q2 2025 | $279.8M | +254% |
| Q1 2025 | $47.6M | +$225.1M |
| Q4 2024 | $137.3M | -69% |
PII has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
PII Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +200K shares |
| 1 year | +2.8% | +1.6M shares |
| 3 years | +1.2% | +700K shares |
| 5 years | -6.1% | -3.8M shares |
| Available history | -6.1% | -3.8M shares |
PII has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $100,000 |
| Q1 2026 | $9.2M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $2.4M |
| Q4 2024 | $400,000 |
PII spent $9M buying back its own shares over the past year, about three times what it spent the year before.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PII Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 10.5x | High |
| Q2 2026 | 21.0x | High |
| Q3 2025 | 4.2x | High |
| Q2 2025 | 3.9x | Elevated |
| Q1 2025 | 3.4x | Elevated |
| Q4 2024 | 3.1x | Elevated |
| Q3 2024 | 2.9x | Moderate |
| Q2 2024 | 2.4x | Moderate |
PII's net debt is about 10 years of its operating earnings (EBITDA), up from 3.4 years a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
PII Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.6 | Neutral |
| Stochastic | 51.1 | Neutral |
PII's weekly RSI is 55 (neutral) and its Stochastic is 51 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
PII PE vs Consumer Cyclical Sector
| Metric | PII | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
PII has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
PII Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $56.6 | 14% above |
| 20 week MA | $62.0 | 4.3% above |
| 50 week MA | $63.5 | 2% above |
| 100 week MA | $56.8 | 14% above |
| 200 week MA | $76.1 | 15% below |
PII has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
PII Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.4 | $98.7 | -2.6% |
| 2021 | $98.7 | $106.3 | +7.6% |
| 2022 | $106.3 | $100.8 | -5.2% |
| 2023 | $100.8 | $94.8 | -6% |
| 2024 | $94.8 | $57.4 | -39% |
| 2025 | $57.4 | $66.3 | +15% |
| 2026 YTD | $66.3 | $64.7 | -2.4% |
PII has the edge over LCID on returns for 2026, with the stronger performance.